Bullous erythema multiforme post Corbevax anti-COVID-19 vaccine: case report.

Authors

  • M. Dave
  • H. Mehta
  • D. Nimbark

DOI:

https://doi.org/10.26326/2281-9649.32.4.2403

Keywords:

vaccine, COVID 19, erythema multiforme

Abstract

Vaccination against COVID-19 is key to reducing the impact of the disease. However, both COVID-19 and its vaccination can cause skin reactions. There are studies showing a link between erythema multiforme and COVID-19 infection; in some cases erythema multiforme can follow the anti-COVID-19 vaccination. The current report describes a case of bullous erythema multiforme that developed in a teenager after the Corbevax vaccine.

Downloads

Published

2022-11-21

How to Cite

Dave, M., Mehta, H., & Nimbark, D. (2022). Bullous erythema multiforme post Corbevax anti-COVID-19 vaccine: case report. European Journal of Pediatric Dermatology, 32(4), 218–21. https://doi.org/10.26326/2281-9649.32.4.2403

Issue

Vol. 32 No. 4 (2022)

Section

Original articles